A Magyar Relaxációs és Szimbólumterápiás Egyesület 2010. július 8–10 között tartja V. Nemzetközi Kongresszusát a Károli Gáspár Református Egyetem Pszichológiai Tanszéke termeiben (1037 Budapest, III. kerület, Bécsi út 324.) A kongresszus alaptémája: Személyes épülés a köz javára -a relaxációs és szimbólumterápiák lehetőségeinek kiteljesítése és a jövő iránti felelőssége.

A témaválasztás alapgondolata:
Korunkban a személyes problematikát felülírja ill. felerősíti a kollektív tudat zavara, értékválsága, irányvesztése, támpontnélkülisége, periférikussága, differenciálatlansága - és nem tud ellensúlyt létrehozni a kollektív tudattalan betörésével és elsodró erejével szemben. Fontos lenne, hogy a pszichoterápiás munka során nagyobb figyelmet fordítsunk a kollektív tudat beáramlása és befolyása felismerésére, hogy a személy belső világa kellő önvédelemhez jusson, meglelje, megtartsa, kibontakoztassa, de legalábbis megtarthassa önmagát.
Az Egyesület már több szálon hozzákezdett a közösségi – kollektív tudat és a személyes létezés különféle jelenségeinek kutatásához. A kongresszusig mindnyájunk számára elegendő idő van kutatást elkezdeni és véghezvinni, amiknek az eredményeit szeretnénk a kongresszuson bemutatni.

A kongresszushoz csatlakozó külföldi társaságok:

• Société Française de Relaxation Psychothérapique (SFRP)


• Asociatia Românā de Psihoterapie prin Relaxare, Simboluri (ARPRS)


• Inštitut Relaxačnej a Symbolickej Psychoterapie (IRSP)


• Italian Commette for the Study of the Autogenic Therapy and Psychotherapy (ICSAT)

Kérjük, hogy részvételi szándékotokat jelezzétek, akár kutatási eredmények bemutatásával, akár egyszerűen résztvevőként kívántok jelen lenni!

dr. Szőnyi Magda
Tanulmányi felelős, főszervező

Generalised Pustular Psoriasis (GPP) – a serious rare disease and its treatment


Hereby we cordially invite you to the international webinar on Generalized Pustular Psoriasis, which will take place on June 6th from 4:00 p.m. to 5:00 p.m.

Prof. Wolf (Department of Dermatology, Medical University of Graz, Austria) and Prof. Pavlovsky (Department of Dermatology, University of Tel Aviv, Israel) will discuss the characteristics and challenges of this rare disease and concrete treatment experiences, with a focus on first experiences with spesolimab in this indication.

You can find more information about this event and the link to register in the invitation attached.

Registration:
To access the webinar, please use the following link to register for the event: REGISTRATION

After registration, you will receive an exclusive link to access the webinar

Time: Tuesday, 6th of June 2023 | 16:00-17:00 | Central European Summertime (UTC+2)

Agenda:
16:00-16:05 Welcome and Introduction
16:05-16:20 Pathophysiology, diagnosis and treatment of GPP P. Wolf
16:20-16:35 Practical treatment experiences in GPP L. Pavlovsky
16.35-17:00 Discussion

Prof. Peter Wolf, MD
Peter Wolf, MD, is Professor of Dermatology and Chair of the Department of Dermatology at the Medical University Graz, Austria. Dr. Wolf has long-standing clinical and research interests in inflammatory skin diseases including GPP. He is the principal investigator of numerous previous and ongoing clinical trials investigating novel treatment strategies in skin diseases. As an active member of the PhD programme Molecular Medicine (MOLMED) of the Medical University of Graz his translational research group addresses mechanistic issues of dermatological treatments.

Prof. Lev Pavlovsky
Dr. Lev Pavlovsky, a Clinical Associate Professor of Dermatology at Tel Aviv University‘s Medical School in Israel, is the Director of the Psoriasis Treatment Service at Rabin Medical Center. With particular expertise in immunobiological treatments, he has led several international clinical trials and authored numerous scientific publications and book chapters. Dr. Pavlovsky also serves as a Councilor at the International Psoriasis Council and the National Representative in the SPIN network.

Generalised Pustular Psoriasis (GPP) – a serious rare disease and its treatment


Hereby we cordially invite you to the international webinar on Generalized Pustular Psoriasis, which will take place on June 6th from 4:00 p.m. to 5:00 p.m.

Prof. Wolf (Department of Dermatology, Medical University of Graz, Austria) and Prof. Pavlovsky (Department of Dermatology, University of Tel Aviv, Israel) will discuss the characteristics and challenges of this rare disease and concrete treatment experiences, with a focus on first experiences with spesolimab in this indication.

You can find more information about this event and the link to register in the invitation attached.

Registration:
To access the webinar, please use the following link to register for the event: REGISTRATION

After registration, you will receive an exclusive link to access the webinar

Time: Tuesday, 6th of June 2023 | 16:00-17:00 | Central European Summertime (UTC+2)

Agenda:
16:00-16:05 Welcome and Introduction
16:05-16:20 Pathophysiology, diagnosis and treatment of GPP P. Wolf
16:20-16:35 Practical treatment experiences in GPP L. Pavlovsky
16.35-17:00 Discussion

Prof. Peter Wolf, MD
Peter Wolf, MD, is Professor of Dermatology and Chair of the Department of Dermatology at the Medical University Graz, Austria. Dr. Wolf has long-standing clinical and research interests in inflammatory skin diseases including GPP. He is the principal investigator of numerous previous and ongoing clinical trials investigating novel treatment strategies in skin diseases. As an active member of the PhD programme Molecular Medicine (MOLMED) of the Medical University of Graz his translational research group addresses mechanistic issues of dermatological treatments.

Prof. Lev Pavlovsky
Dr. Lev Pavlovsky, a Clinical Associate Professor of Dermatology at Tel Aviv University‘s Medical School in Israel, is the Director of the Psoriasis Treatment Service at Rabin Medical Center. With particular expertise in immunobiological treatments, he has led several international clinical trials and authored numerous scientific publications and book chapters. Dr. Pavlovsky also serves as a Councilor at the International Psoriasis Council and the National Representative in the SPIN network.